The Use of Liposomal Bupivacaine in Erector Spinae Plane Block to Minimize Opioid Consumption for Breast Surgery: A Case Report: Erratum
Publication
, Journal Article
Published in: A&A Practice
January 1, 2020
Duke Scholars
Published In
A&A Practice
DOI
EISSN
2575-3126
Publication Date
January 1, 2020
Volume
14
Issue
1
Start / End Page
36 / 36
Publisher
Ovid Technologies (Wolters Kluwer Health)
Citation
APA
Chicago
ICMJE
MLA
NLM
The Use of Liposomal Bupivacaine in Erector Spinae Plane Block to Minimize Opioid Consumption for Breast Surgery: A Case Report: Erratum. (2020). A&A Practice, 14(1), 36–36. https://doi.org/10.1213/xaa.0000000000001136
“The Use of Liposomal Bupivacaine in Erector Spinae Plane Block to Minimize Opioid Consumption for Breast Surgery: A Case Report: Erratum.” A&A Practice 14, no. 1 (January 1, 2020): 36–36. https://doi.org/10.1213/xaa.0000000000001136.
The Use of Liposomal Bupivacaine in Erector Spinae Plane Block to Minimize Opioid Consumption for Breast Surgery: A Case Report: Erratum. A&A Practice. 2020 Jan 1;14(1):36–36.
“The Use of Liposomal Bupivacaine in Erector Spinae Plane Block to Minimize Opioid Consumption for Breast Surgery: A Case Report: Erratum.” A&A Practice, vol. 14, no. 1, Ovid Technologies (Wolters Kluwer Health), Jan. 2020, pp. 36–36. Crossref, doi:10.1213/xaa.0000000000001136.
The Use of Liposomal Bupivacaine in Erector Spinae Plane Block to Minimize Opioid Consumption for Breast Surgery: A Case Report: Erratum. A&A Practice. Ovid Technologies (Wolters Kluwer Health); 2020 Jan 1;14(1):36–36.
Published In
A&A Practice
DOI
EISSN
2575-3126
Publication Date
January 1, 2020
Volume
14
Issue
1
Start / End Page
36 / 36
Publisher
Ovid Technologies (Wolters Kluwer Health)